Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This month, Dr Iztok Urbančič joined Christian Eggeling's lab in the MRC Human Immunology Unit, supported by a prestigious Marie Skłodowska-Curie postdoctoral fellowship.

Iztok completed his studies in physics in 2009 at the University of Ljubljana, Slovenia, and obtained his PhD in biophysics in 2013 from the University of Maribor, Slovenia. During his 2-year fellowship here at the MRC WIMM, he will work on further improving super-resolution STED microscopy by introducing spectrally resolved detection in combination with environment selective probes. He will use these advancements to gain further insight into changes of molecular membrane organization and dynamics during immune cell activation.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

MRC HIU appoints new Director

Department General MRC HIU MRC WIMM

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

2020 RDM graduate prize winners

CVM Department General MRC WIMM

Many congratulations to Alba Rodriguez Meira and Ioannis Akoumianakis for winning this year's RDM graduate prize.

Role-playing computer game helps players understand how vaccines work on a global scale

COVID-19 research IMD MRC HIU MRC WIMM

A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.

Researchers target previously unknown ‘genetic vulnerability’ in breast cancer cells

Department General MRC HIU MRC WIMM Publication Research

New Nature paper reports on a genetic vulnerability in nearly 10% of breast cancer tumours, which could be targeted to selectively kill cancer cells.